Step 1 topics → Gastrointestinal → Esophageal Varices

Esophageal Varices

USMLE Step 1 trap: Confuses direct wall injury with portosystemic shunting as the mechanism of varix formation. Portal hypertension causes blood to shunt through portosystemic anastomoses (left gastric → esophageal submucosal veins), dilating them into varices.

Esophageal varices are dilated submucosal veins in the distal esophagus that form when portal hypertension forces blood through portosystemic anastomoses — specifically the left gastric vein into the esophageal venous plexus. They matter on USMLE Step 1 because they sit at the intersection of anatomy (portal-caval anastomoses), pathophysiology (portal HTN from cirrhosis), and clinical management (a high-stakes bleed scenario). The exam will test all three levels: pure recall of which anastomosis is involved, application of mechanism to explain why a cirrhotic patient vomits blood, and passage-based questions where you have to identify the right intervention at the right step.

The trickiest part is keeping the management hierarchy straight. Students routinely confuse what's first-line vs rescue, and they misplace non-selective beta-blockers as only a secondary prophylaxis tool. USMLE Step 1 loves to test whether you know that propranolol is appropriate before a first bleed has ever occurred, not just after. The pharmacology of octreotide also trips people up — it's not doing anything directly to the varix itself, and understanding its indirect mechanism through splanchnic vasoconstriction is exactly what the exam probes.

Build your mental model around pressure, not injury. Varices aren't caused by the portal system damaging the esophagus — they're caused by blood finding an alternate route and engorging vessels that weren't built to carry that load. Once that's clear, the pathogenesis, the rationale for beta-blockers, and the logic of octreotide all fall into place. On USMLE Step 1, connecting mechanism to management is what separates a correct answer from a confident wrong one.

From real student decks
54%have cards covering this topic
30%have mature cards

Common misconceptions

Common mistake
Wrong: Esophageal varices form because portal hypertension directly damages the esophageal wall.
Right: Portal hypertension causes blood to shunt through portosystemic anastomoses (left gastric → esophageal submucosal veins), dilating them into varices.
Portal hypertension doesn't injure the esophageal wall — it reroutes blood. When portal pressure rises, blood backs up and finds low-resistance collateral paths, including the left gastric (coronary) vein, which drains into the submucosal venous plexus of the esophagus. These vessels dilate under the increased flow and pressure, forming varices. The wall itself is passive here; the problem is hydraulic, not inflammatory.
Common mistake
Wrong: Non-selective beta-blockers are used only for secondary prophylaxis after a variceal bleed.
Right: Non-selective beta-blockers (propranolol, nadolol) are indicated for primary prophylaxis in patients with medium-to-large varices who have never bled.
Non-selective beta-blockers (propranolol, nadolol) are first-line primary prophylaxis for patients with medium-to-large varices who have never had a bleed. They work by reducing cardiac output (β1) and allowing splanchnic vasoconstriction (β2 blockade removes vasodilatory tone), both of which lower portal pressure. Restricting them to secondary prophylaxis is a significant error — the whole point is preventing the first bleed, which carries substantial mortality.
Common mistake
Wrong: Octreotide stops variceal bleeding by directly constricting the varices.
Right: Octreotide inhibits glucagon and other vasodilatory peptides, causing splanchnic vasoconstriction and reducing portal pressure.
Octreotide doesn't squeeze the varix directly. It's a somatostatin analogue that inhibits glucagon and other splanchnic vasodilatory peptides. Less glucagon means less splanchnic vasodilation, which reduces blood flow into the portal system and lowers portal pressure indirectly. Understanding this mechanism explains why it's paired with endoscopic therapy — it controls the hemodynamic environment while EVL addresses the bleeding vessel itself.
Common mistake
Wrong: TIPS is the first-line rescue therapy and endoscopic band ligation is reserved for refractory cases.
Right: Endoscopic band ligation is first-line treatment for acute variceal bleeding; TIPS is rescue therapy when endoscopic and pharmacologic management fails.
Endoscopic band ligation is first-line for acute variceal bleeding — it mechanically obliterates the bleeding varix directly and is performed at the same time as diagnostic endoscopy. TIPS (transjugular intrahepatic portosystemic shunt) is a rescue procedure reserved for patients who fail combined endoscopic and pharmacologic management, or for refractory/recurrent bleeding. Inverting this hierarchy would mean going straight to an invasive IR procedure when a safer endoscopic option should be tried first.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Explain how portal hypertension leads to esophageal varices through portosystemic shunting — specifically the left gastric vein to esophageal submucosal veins — rather than through any direct injury to the esophageal wall.
  2. Identify the components of the acute variceal bleed management bundle: IV octreotide, endoscopic band ligation (EVL) as first-line endoscopic therapy, antibiotics (e.g., ceftriaxone), and TIPS as rescue when endoscopic plus pharmacologic therapy fails.
  3. Distinguish primary prophylaxis (non-selective beta-blockers or EVL for patients with medium-to-large varices who have never bled) from secondary prophylaxis (combination of non-selective beta-blockers plus EVL after a first bleed has occurred).

Can you avoid these mistakes?

A 52-year-old man with cirrhosis presents with hematemesis. Endoscopy shows actively bleeding esophageal varices. What is the first-line endoscopic treatment, what pharmacologic agent should already be running, and under what circumstances would you escalate to TIPS?
A patient with cirrhosis is found on surveillance endoscopy to have large esophageal varices. They have never had a variceal bleed. What is the appropriate prophylactic intervention, and what is the mechanism by which it reduces bleeding risk?
Explain why esophageal varices form specifically at the distal esophagus in portal hypertension — trace the anatomic path from elevated portal pressure to a dilated submucosal esophageal vein.
Your attending says octreotide 'constricts the varices directly.' Is this correct? What is the actual mechanism, and how does knowing it help you predict its side effects and appropriate use?

Related topics

Portal-Caval Anastomoses Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →